Poehling Capital Management’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,930
Closed -$246K – 144
2021
Q3
$246K Buy
1,930
+15
+0.8% +$1.98K 0.08% 122
2021
Q2
$241K Sell
1,915
-15
-0.8% -$1.84K 0.08% 133
2021
Q1
$225K Hold
1,930
– – 0.08% 139
2020
Q4
$219K Buy
+1,930
New +$211K 0.09% 119
2020
Q1
– Sell
-2,081
Closed -$212K – 123
2019
Q4
$212K Buy
+2,081
New +$200K 0.14% 102
2019
Q3
– Sell
-2,225
Closed -$206K – 109
2019
Q2
$206K Sell
2,225
-10
-0.4% -$899 0.14% 100
2019
Q1
$205K Buy
+2,235
New +$202K 0.15% 97
2018
Q4
– Sell
-2,176
Closed -$207K – 106
2018
Q3
$207K Buy
2,176
+315
+17% +$28.5K 0.15% 99
2018
Q2
$155K Buy
1,861
+1,717
+1,192% +$142K 0.14% 103
2018
Q1
$12K Buy
+144
New +$12.3K 0.01% 227

Other funds holding XLV

Poehling Capital Management's XLV Position: Q4 2021 in Review

Poehling Capital Management sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2021, closing a stake of 1,930 shares — an estimated $246K sold.

Poehling Capital Management first reported a position in XLV in Q1 2018 and held it in 10 quarters. The position peaked at $246K in Q3 2021. 1,443 funds tracked by Wall St. Rank hold XLV as of Q4 2021.

  • Poehling Capital Management reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2021 after selling out during the quarter.
  • Poehling Capital Management sold 1,930 State Street Health Care Select Sector SPDR ETF shares in Q4 2021, an estimated $246K.
  • Poehling Capital Management first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2018 and held it in 10 quarters.
  • Poehling Capital Management's State Street Health Care Select Sector SPDR ETF position peaked at $246K in Q3 2021.
  • 1,443 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2021.

Based on Poehling Capital Management's 13F filing for Q4 2021, filed 10 Jan 2022.